Cohort Study: Perioperative Management of Patients with Atrial Fibrillation Receiving a Direct Oral Anticoagulant
6 Aug, 2019 | 08:10h | UTCPerioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant – JAMA Internal Medicine (free for a limited period)
Commentary: Study Sheds Light on Stopping and Resuming DOACs in Afib Patients Undergoing Surgery – NEJM Journal Watch (free)
“The DOAC regimens were omitted for 1 day before a low–bleeding-risk procedure and 2 days before a high–bleeding-risk procedure. The DOAC regimens were resumed 1 day after a low–bleeding-risk procedure and 2 to 3 days after a high–bleeding-risk procedure.”
Related Commentary on Twitter
PAUSE is the largest trial to date that addresses perioperative DOAC timing and demonstrates safe management with the ability to influence guidelines https://t.co/WDM3yWt9nA
— JAMA Internal Medicine (@JAMAInternalMed) August 5, 2019